Ravi Rao
Director/Board Member presso DBV TECHNOLOGIES
Patrimonio netto: 9 828 $ in data 31/03/2024
Profilo
Il Dr. Ravi M. Rao è Chief Medical Officer presso Swedish Orphan Biovitrum AB e membro del Royal College of Physicians. Fa parte del consiglio di amministrazione di DBV Technologies SA. Il dottor Rao è stato precedentemente impiegato come Chief Medical Officer presso Aeglea Biotherapeutics, Inc. e Head-Global Medical Affairs presso GlaxoSmithKline Plc. Si è laureato all'Università di Cambridge e ha conseguito un dottorato all'Imperial College di Londra.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
DBV TECHNOLOGIES SA
0.01% | 15/02/2023 | 6 837 ( 0.01% ) | 9 828 $ | 31/03/2024 |
Posizioni attive di Ravi Rao
| Società | Posizione | Inizio |
|---|---|---|
| DBV TECHNOLOGIES | Director/Board Member | 19/05/2021 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 01/04/2024 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/04/2022 |
Precedenti posizioni note di Ravi Rao
| Società | Posizione | Fine |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 01/01/2022 |
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10/08/2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | - |
Formazione di Ravi Rao
| Imperial College London | Doctorate Degree |
| University of Cambridge | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Ravi Rao
